shortstartup.com
No Result
View All Result
  • Home
  • Business
  • Investing
  • Economy
  • Crypto News
    • Ethereum News
    • Bitcoin News
    • Ripple News
    • Altcoin News
    • Blockchain News
    • Litecoin News
  • AI
  • Stock Market
  • Personal Finance
  • Markets
    • Market Research
    • Market Analysis
  • Startups
  • Insurance
  • More
    • Real Estate
    • Forex
    • Fintech
No Result
View All Result
shortstartup.com
No Result
View All Result
Home Forex

Apple shares not loving details from the WWDC 2025

Apple shares not loving details from the WWDC 2025
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


The Apple Worldwide Developers Conference (WWDC) has so far lacked meaningful AI-related announcements, with only vague comments that AI features are “coming” for developers. In response, Apple’s stock is trading lower, down $3.25 (-1.61%) at $200.70.

Apple stock

From a technical perspective, today’s decline pushes the price below both the 100- and 200-hour moving averages, which sit at $202.02 and $204.10, respectively. The price has also slipped beneath the 38.2% retracement level of the move from the late 2024 all-time high to the 2025 low at $169.21. That retracement level, located at $203.93, overlaps closely with the MAs, increasing the importance of this technical resistance zone.

As long as the price remains below these levels, the short-term technical bias favors the sellers. A move back above the cluster of resistance would be needed to tilt momentum back in favor of the bulls.

Later this year,
ForexLive.com
is evolving into
investingLive.com, a new destination for intelligent market updates and smarter
decision-making for investors and traders alike.



Source link

Tags: AppleDetailslovingSharesWWDC
Previous Post

CEO recession expectations decline from April scare, survey says

Next Post

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Next Post
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

shortstartup.com

Categories

  • AI
  • Altcoin News
  • Bitcoin News
  • Blockchain News
  • Business
  • Crypto News
  • Economy
  • Ethereum News
  • Fintech
  • Forex
  • Insurance
  • Investing
  • Litecoin News
  • Market Analysis
  • Market Research
  • Markets
  • Personal Finance
  • Real Estate
  • Ripple News
  • Startups
  • Stock Market
  • Uncategorized

Recent News

  • Should I pull the trigger on the new vehicle? My current one is getting old.
  • XRP Price Could Surge To $15 As Crypto Analyst Predicts ‘XRP Summer’
  • Crypto Products See ‘Noticeable Deceleration’ of Inflows As Monetary Policy Uncertainty Grows: CoinShares
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy
  • Terms and Conditions

Copyright © 2024 Short Startup.
Short Startup is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Business
  • Investing
  • Economy
  • Crypto News
    • Ethereum News
    • Bitcoin News
    • Ripple News
    • Altcoin News
    • Blockchain News
    • Litecoin News
  • AI
  • Stock Market
  • Personal Finance
  • Markets
    • Market Research
    • Market Analysis
  • Startups
  • Insurance
  • More
    • Real Estate
    • Forex
    • Fintech

Copyright © 2024 Short Startup.
Short Startup is not responsible for the content of external sites.